Abstract
The results of controlled non-human animal and human laboratory studies are mixed regarding whether women and men respond differently to stimulant drugs. In order to assess potential gender differences in the effects of d-amphetamine, we conducted a retrospective analysis of six studies conducted in our laboratory that used identical procedures and measures. Thirteen women and fourteen men learned to discriminate 15 mg oral d-amphetamine. After acquiring the discrimination (i.e., ≥ 80% correct responding on 4 consecutive sessions), the effects of a range of doses of d-amphetamine (0, 2.5, 5, 10, and 15 mg) alone and in combination with other drugs, were assessed. Only data from sessions in which d-amphetamine was administered alone were included in this analysis. d-Amphetamine functioned as a discriminative stimulus and dose-dependently increased drug-appropriate responding. Women and men did not differ in their ability to discriminate d-amphetamine. Women and men differed on participant-ratings of high (women < men), nausea (women > men) and sluggish (women < men), women also experienced greater increases in diastolic pressure than men. Because the results of this study may have been confounded by the training procedures, future research should use other behavioral arrangements (e.g. drug self-administration) to determine if women and men respond differently to the effects of d-amphetamine.
Original language | English |
---|---|
Pages (from-to) | 289-296 |
Number of pages | 8 |
Journal | Pharmacology Biochemistry and Behavior |
Volume | 87 |
Issue number | 2 |
DOIs | |
State | Published - Jun 2007 |
Bibliographical note
Funding Information:The authors wish to thank Frances P. Wagner, R.N., for her expert nursing assistance and Michelle Gray, Derek Roe, John Blackburn, Jamie Haga, Allison Weber, Abigail Osborne, Matt Weaver, Brad Cooper and Joe Kingery for their expert technical assistance. The National Institute on Drug Abuse Grants DA (RO1) 10325, 017711, and 13567 (C.R.R.) as well as DA (T32) 007304 (Thomas Garrity) supported this research.
Funding
The authors wish to thank Frances P. Wagner, R.N., for her expert nursing assistance and Michelle Gray, Derek Roe, John Blackburn, Jamie Haga, Allison Weber, Abigail Osborne, Matt Weaver, Brad Cooper and Joe Kingery for their expert technical assistance. The National Institute on Drug Abuse Grants DA (RO1) 10325, 017711, and 13567 (C.R.R.) as well as DA (T32) 007304 (Thomas Garrity) supported this research.
Funders | Funder number |
---|---|
National Institute on Drug Abuse | 017711, 007304, R01DA017711, 10325, 13567 |
Keywords
- Amphetamine
- Cardiovascular effects
- Drug discrimination
- Sex
- Subjective effects
ASJC Scopus subject areas
- Biochemistry
- Toxicology
- Pharmacology
- Clinical Biochemistry
- Biological Psychiatry
- Behavioral Neuroscience